EZH2作为胃肠道癌症的潜在治疗标
Mehrdad Hashemi1, Naghmeh Nazdari2, Ghazaleh Gholamiyan2
1Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
增强肠胃同源2 (EZH2) 驱动胃肠癌的进展,并影响治疗反应. 向EZH2提供了一个有希望的治疗策略,用于改善肠道癌症患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 胃肠道 (GI) 癌症是一个重大的全球健康负担,需要对其分子基础有更深入的了解.
- 增强酶同源2 (EZH2) 是一种关键的表观遗传调节剂,与基因表达和癌症发展有关.
- 在各种胃肠道恶性瘤中观察到不规则的EZH2表达.
研究的目的:
- 审查EZH2信号传导在各种肠道癌症进展中的多方面的作用.
- 探索EZH2在肠道恶性瘤中对化疗和放射治疗反应的影响.
- 检查胃肠道癌症中EZH2的上游调节器和治疗向策略.
主要方法:
- 文献综述侧重于EZH2在结直肠,胃,胰腺,肝细胞,食道和胆管癌中的功能.
- 分析EZH2对癌细胞增殖,迁移和治疗敏感性的影响.
- 研究上游调节途径 (例如,lncRNAs,miRNAs) 和新兴的EZH2向疗法.
主要成果:
- 在胃肠道癌症中,EZH2信号加速癌细胞的进展.
- EZH2表达水平与预后相关,表达水平较高表明结果较差.
- 在胃肠道癌症中,EZH2调节了对化疗和放射治疗的敏感性.
- 上游调节者,如长非编码RNA和微RNA,影响EZH2活动.
结论:
- EZH2是肠胃癌进展的关键驱动因素,也是潜在的预后生物标志物.
- 通过基因疗法和抗瘤药物向EZH2为新的肠道癌症治疗提供了一个有希望的途径.
- 对EZH2通路的进一步研究可以带来增强的治疗策略和改善患者的治疗结果.
更多相关视频
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
06:19Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
